BRIDGEWATER, N.J., Nov. 1, 2018 /PRNewswire/ -- Sanofi has
expanded its access program for people living with diabetes to
include all Sanofi insulins*, helping patients get the insulin they
need at a significantly reduced price.
Sanofi's Insulins VALyou Savings Program debuted earlier this
year, offering qualifying patients the opportunity to obtain two of
Sanofi's insulins at a set price. Beginning today, the program will
now include all Sanofi insulins. Since its April launch, over 6,500
people living with diabetes have enrolled and taken advantage of
the benefits of the program.
This program is available at U.S. pharmacies and offers all
Sanofi insulins at one set price: $99 for a 10 mL vial
or $149 for a box of pens. For some people, the program
could offer a savings of up to $3,000
per year.
"When we initially launched the Insulins VALyou Savings
Program, our goal was to support as many uninsured and underinsured
people living with diabetes as we could, and we pledged to explore
how to increase affordable access in the future," said Michelle Carnahan, North America Head of
Diabetes and Cardiovascular, Sanofi. "We're making good on that
pledge today by expanding this program. While we are off to a good
start, we know that many people continue to look for more
affordable insulin options. We hope the expansion and increased
awareness of this program will allow more people to benefit from
it."
All uninsured and commercially insured patients are eligible to
participate in the Insulins VALyou Savings Program. This includes
cash-paying patients who don't qualify for traditional patient
assistance programs, can't take advantage of our commercial co-pay
offers, or haven't reached their high deductible on their
commercial insurance. While under current regulations
pharmaceutical companies cannot offer this type of program to
patients insured under Medicare, Medicaid, or similar federal or
state programs, Sanofi supports efforts that would expand this
access program to all those who might benefit.
Sanofi continues to offer other resources to make insulins more
affordable including co-pay cards which may limit out-of-pocket
expenses to as low as $0 for
eligible, commercially insured patients. In addition, Sanofi
offers assistance programs that provide medications, including
insulin, at no charge for qualified low-income, uninsured patients
through the patient assistance component of the Sanofi Patient
Connection program. Together, these programs demonstrate the
company's dedication to find support to help people living with
diabetes gain access to the insulins they need.
For more information, visit www.InsulinsVALyou.com. Sanofi also
encourages anyone who is prescribed a Sanofi medicine, and who may
be having financial challenges or trouble navigating their
insurance, to call Sanofi Patient Connection at (888) 847-4877
where eligible patients can be connected to the medicines and
resources they need at no cost.
* The Insulins VALyou Savings Program excludes Sanofi's
combination insulin product.
SAUS.ILI.18.10.6085
View original content to download
multimedia:http://www.prnewswire.com/news-releases/sanofi-expands-insulins-valyou-savings-program-helping-more-people-living-with-diabetes-300741477.html
SOURCE Sanofi